SCHEMBL266829

SCHEMBL266829

CCC(CC)CCS(=O)(=O)O

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.38
PDE4A P27815 1/20 0.38
LMNA P02545 1/20 0.38
SLC6A6 P31641 1/20 0.38
CYP2C19 P33261 1/20 0.38
BLM P54132 1/20 0.38
S1PR2 O95136 1/20 0.35
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
ENPEP Q07075 6/20 0.35
APP P05067 1/20 0.35
RECQL P46063 1/20 0.33
TP53 P04637 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GCLC P48506 1/20 0.31
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29714065 0.88 CA2 (0.38) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL26305899 0.88 ALDH1A1 (0.48) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL26687322 0.86 ALDH1A1 (0.46) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL15555634 0.85 APP (0.42) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL752580 0.84 RECQL (0.38) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL12786130 0.84 ENPEP (0.34) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL9342210 0.84 CA2 (0.50) LMNAS1PR2S1PR1S1PR3RECQL
SCHEMBL15555808 0.83 APP (0.41) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL7057225 0.83 PTGS1 (0.45) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL8813255 0.83 TP53 (0.52) LMNAS1PR2S1PR1S1PR3RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114291922-A Method and device for removing radionuclide in water 江苏埃梯恩膜过滤技术有限公司 2022-04-08 CN claimed
US-20260034124-A1 NOVEL SALTS AND CRYSTALS INTRA CELLULAR THERAPIES INC (US) 2026-02-05 US disclosed
US-9568647-B2 Optical film having antistatic layer, polarizing plate, and image display device FUJIFILM CORPORATION (JP) 2017-02-14 US disclosed
US-20140141235-A1 OPTICAL FILM HAVING ANTISTATIC LAYER, POLARIZING PLATE, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2014-05-22 US disclosed
US-8673182-B2 Optical film having antistatic layer, polarizing plate and image display device FUJIFILM CORPORATION (JP) 2014-03-18 US disclosed
US-8133581-B2 Electroconductive polymer composition, electroconductive polymer material and method for producing electroconductive polymer material FUJIFILM CORPORATION (JP) 2012-03-13 US disclosed
US-20110049435-A1 Optical film having antistatic layer, polarizing plate and image display device FUJIFILM CORPORATION (JP) 2011-03-03 US disclosed
US-20100136329-A1 ELECTROCONDUCTIVE POLYMER COMPOSITION, ELECTROCONDUCTIVE POLYMER MATERIAL AND METHOD FOR PRODUCING ELECTROCONDUCTIVE POLYMER MATERIAL FUJIFILM CORPORATION (JP) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260034124-A1 NOVEL SALTS AND CRYSTALS SLC6A4, SLC6A3, HTR2A PTGS1 1038/4885PDE4A 859/4885LMNA 2615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.